Browse
···
Log in / Register

Earn for Participation - Multiple Sclerosis (Chandler)

$100/day

Dobson Rd & Frye Rd, Chandler, AZ 85224, USA

Favourites
Share

Description

Unlock New Hope: Join Our Clinical Study for Multiple Sclerosis! Are you living with Multiple Sclerosis (MS)? We are seeking patient volunteers to participate in a clinical research testing a new medication for MS. The medication is provided at no cost to you or your insurance, and you will be compensated for your time and travel. Plus, refer a friend who qualifies and earn a $100 BONUS! Join us in advancing MS treatment today.  Call 480-716-4590 Now! Or Apply Here WHY PARTICIPATE? ●Compensation: Get compensated up to $100 per clinic visit with no cost to you or your insurance! ●Comprehensive Support: Regular check-ins and assessments to ensure your health is a priority. Our study is conducted by experienced healthcare professionals dedicated to your well-being. ●No-cost study medications: Study medications for Multiple Sclerosis are given at no charge. TO QUALIFY, YOU MUST: ● Be 18-45 Years Old ● Have a Clinical Diagnosis of Multiple Sclerosis Check out our other studies! ● Excessive Sleepiness Due to Shift Work ● Narcolepsy and Idiopathic Hypersomnia ● General Anxiety Disorder ● Asthma Treatment ● Diabetes ● Cardiovascular Risk Factor Study ● Future Studies AND MANY MORE! Chandler Clinical Trials (CCT) Contact us today at 480-716-4590 or visit us at https://chandlertrials.com/ for more details! Advancing Medicine Through Research!

Source:  craigslist View original post

Location
Dobson Rd & Frye Rd, Chandler, AZ 85224, USA
Show map

craigslist

You may also like

Craigslist
Alastin Skincare Clinical Research Study (Carlsbad)
PURPOSE OF STUDY: Alastin Skincare is conducting a 14-Week research study to evaluate the effects of an investigational topical body lotion for improving body skin quality. The study Test Product may improve the appearance of your skin but cannot be guaranteed. Study participants will apply the study Test Product twice daily ONLY to the assigned body areas (1 knee & 1 upper inner arm) and use an approved body cleanser and sunscreen for the duration of the study. No products will be used on the untreated side (knee & upper inner arm). To be considered for study participation, you must: • Be a healthy female or male ages 40 to 75 years. • Have Moderate to Severe crepey (crinkly) skin of the upper inner arms & knees. • Have Mild to Severe laxity (loose) skin of the upper inner arms & knees. • Have Mild to Severe skin roughness & dryness of the upper inner arms & knees. • Be willing to use ONLY the study provided Test Product, body cleanser, and sunscreen for the duration of the study (14 weeks). • Be willing to NOT undergo ANY cosmetic procedures on the upper arms & knees for the duration of the study (14 weeks). • Be available to visit the office 5 times during the study period (14 weeks). • Be willing to have photographs taken of your upper arms & knees, and sign a photography release authorizing Alastin Skincare, Inc. to use and/or publish your photographs for promotional purposes. • Be willing to maintain a consistent body weight for the duration of the study. Individuals currently undergoing weight loss treatments can be considered for study participation, provided the dose is stable and a consistent body weight is maintained for the duration of the study (14 weeks). • Meet additional study qualification criteria. Eligible individuals that meet all study qualification criteria and complete ALL study visits will be compensated for their time and travel in the amount of $250 ($50 per study visit) and offered to choose any three (3) Alastin commercially available products, which can be valued at a retail cost up to $700. STUDY LOCATION & CONTACT: Galderma; Alastin Skincare, Inc. 5999 Avenida Encinas, Ste 100, Carlsbad, CA 92008 Lora Colvan, R&D Advisor
5999 Avenida Encinas #150, Carlsbad, CA 92008, USA
$250-700/week
Cookie
Cookie Settings
Our Apps
Download
Download on the
APP Store
Download
Get it on
Google Play
© 2025 Servanan International Pte. Ltd.